Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000059.xml
Pneumologie 2020; 74(08): 493-495
DOI: 10.1055/a-1216-5739
DOI: 10.1055/a-1216-5739
Positionspapier der DGP
Therapie mit Dexamethason bei Patienten mit COVID-19
Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.Treatment with Dexamethasone in Patients with COVID-19A Position Paper of the German Respiratory Society (DGP)
Eine aktualisierte Version dieses Beitrags finden Sie unter: https://pneumologie.de/covid-19.
Publication History
Article published online:
16 July 2020
© Georg Thieme Verlag KG
Stuttgart · New York
-
Literatur
- 1 Fachgruppe COVRIIN am RKI. Wann könnte die Einleitung einer antiviralen Therapie gerechtfertigt werden? Stand: 24.06.2020. DOI: 10.25646/6962
- 2 Messner CB, Demichev V, Wendisch D. et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Systems 2020; DOI: 10.1016/j.cels.2020.05.012.
- 3 Li H, Chen C, Hu F. et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia 2020; 34: 1503-1511 https://doi.org/10.1038/s41375-020-0848-3
- 4 Giacobbe DR, Battaglini D, Ball L. et al. Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest 2020; e13319 DOI: 10.1111/eci.13319.
- 5 Horby P, Landray MJ. et al.; RECOVERY Collaborative Group. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. medRxiv 22.06.2020. DOI: 10.1101/2020.06.22.20137273.
- 6 Lewis SR, Pritchard MW, Thomas CM. et al. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev 2019; 7: CD004477
- 7 Villar J, Ferrando C, Martínez D. et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med 2020; 8: 267-276 DOI: 10.1016/S2213-2600(19)30417-5.
- 8 Papazian L, Forel J-M, Gacouin A. et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363: 1107-1116
- 9 Guérin C, Reignier J, Richard J-C. et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368: 2159-2168 DOI: 10.1056/NEJMoa1214103.
- 10 Combes A, Hajage D, Capellier G. et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378: 1965-1975 DOI: 10.1056/NEJMoa1800385.
- 11 Bornstein SR, Rubino F, Khunti K. et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020; 8: 546-550 DOI: 10.1016/S2213-8587(20)30152-2.
- 12 Lloyd M, Karahalios A, Janus E. et al. Improving Evidence-Based Treatment Gaps and Outcomes in Community-Acquired Pneumonia (IMPROVE-GAP) Implementation Team at Western Health. Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients with Community-Acquired Pneumonia: A Stepped-Wedge Randomized Clinical Trial. JAMA Intern Med 2019; 179: 1052-1060 DOI: 10.1001/jamainternmed.2019.1438.